A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Currently, no drugs have been developed for DOR. We developed the Chinese herbal compound TJAOA101 and has validated its effects in animals. Here, we will perform a population-based, multicenter study to confirm the safety and efficacy of TJAOA101 in therapy of DOR. We aim to provide a solid evidence for TCM in therapy of DOR.
Epistemonikos ID: 2710d6e2a642e0dfdfa0d3b8c9256029b70a0f9b
First added on: May 13, 2024